Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of GC1111 in Hunter Syndrome
NCT01301898Phase 2Completed
- Sponsor
- GC Biopharma
- Start
- May 2010
- Primary completion
- Mar 2011
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Idursulfase beta in mucopolysaccharidosis type II, sponsored by GC Biopharma. Started May 2010; status: completed.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT01301898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301898.